A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague
ABSTRACT Bacillus anthracis and Yersinia pestis, the causative agents of anthrax and plague, respectively, are two of the deadliest pathogenic bacteria that have been used as biological warfare agents. Although Biothrax is a licensed vaccine against anthrax, no Food and Drug Administration-approved...
Guardado en:
Autores principales: | Pan Tao, Marthandan Mahalingam, Jingen Zhu, Mahtab Moayeri, Jian Sha, William S. Lawrence, Stephen H. Leppla, Ashok K. Chopra, Venigalla B. Rao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e99a89944ec4a70998d621b245a3deb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COMPLIANCE OF ANTHRAX RECOMBINANT VACCINE PROTOTYPE WITH THE REQUIREMENTS TO IMMUNE-BIOLOGICAL PREPARATIONS
por: N. I. Mikshis, et al.
Publicado: (2018) -
SOME WAYS OF PRODUCTION PROCESS OF LIVE PLAGUE VACCINE AND TECHNIQUES OF EVALUATION THE IMMUNOGENICITY (REVIEW)
por: Zh. A. Konovalova, et al.
Publicado: (2013) -
Efficiency of Human Plague Vaccination in Tuvinian Natural Plague Focus
por: K. M. Korytov, et al.
Publicado: (2019) -
Experience of Using a Complex Antigenic Preparation of the Plague Microbe to Assess the Severity of a Specific Anti-Plague Response
por: V. I. Dubrovina, et al.
Publicado: (2021) -
Efficiency of human plague vaccination in tuvinian natural plague focus. Message 2: dynamics of immune status indicators after revaccination
por: K. M. Korytov, et al.
Publicado: (2021)